All three pathways appear to be involved in the metabolic reprogramming of HCC, with the PI3K/Akt pathway promoting glycolysis while inhibiting gluconeogenesis, the PPAR signaling pathway modulating the PI3K/Akt pathway, and glycolysis playing a central role [37,38]. Here, AKT1 is linked to hepatocellular carcinoma.